Quest for IV safety leads from clean room to Capitol Hill
“If I had a crystal ball to look into the future, I’d want to see an IV workflow system in every hospital that compounds sterile products.”
When it comes to patient safety, sterile compounding is among the highest-risk activities performed by health-system pharmacies. The quest for solutions to reduce this patient risk led Dave Webster to become an early adopter of sterile compounding automation—as well as a noted author, lecturer, and advocate on the subject.
Among other responsibilities, Webster leads sterile compounding operations across multiple sites for the University of Rochester Medical Center. To date, fully automated robots have produced over 170,000 doses for the medical center, including patient-specific oncology doses, with IV workflow devices producing an additional 3,000 doses per month.
University of Rochester Medical Center
- Staff beds1,333
- Medical Staff3,054
- Physician Group4
- Ambulatory Surgery Center3
- Imaging Center9
- Home Health Agency2
- Skilled Nursing Facility5
- Urgent Care Clinic10